NYAX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
["Not a good buy right now for an impatient entry: price ($53.67) is breaking down with bearish momentum (expanding negative MACD) and is sitting just below/around key support (~$54).", "Street price targets skew below the current price (recent PTs $47\u2013$52), suggesting limited near-term upside versus downside if support fails.", "Fundamentals are improving (strong Q3 2025 growth), but the tape is weak today (-5.45% regular session; -2.75% pre-market), and there are no proprietary \u201cmust-buy\u201d signals to override the technical damage."]
["Trend/Momentum: MACD histogram -0.958 and negatively expanding \u2192 bearish momentum is strengthening, consistent with today\u2019s selloff.", "RSI: RSI_6 at 28.05 (near oversold) \u2192 bounce potential exists, but oversold can persist during downtrends; not a clear buy trigger by itself.", "Moving averages: Converging MAs \u2192 transition/chop, but current move is resolving lower rather than higher.", "Key levels: Pivot 56.96 overhead (now resistance). Support S1 53.996 is being tested; next support S2 52.165. A decisive break below ~54 increases odds of a move toward ~52.", "Pattern-based forward look (provided): 60% chance of -1.15% next day, +1.51% next week, +5.14% next month \u2192 near-term still shaky, modest rebound odds later.", "Intellectia Proprietary Trading Signals", "- AI Stock Picker: no signal on given stock today.", "- SwingMax: No signal on given stock recently."]
["Strong latest reported quarter (2025/Q3): revenue +25.63% YoY; EPS +350% YoY; net income +411% YoY; gross margin expanded to 45.49%.", "Potential mean-reversion bounce setup: RSI near oversold while approaching support zone (~$54 / ~$52).", "Next major catalyst: QDEC 2025 earnings on 2026-03-03 (pre-market), which could re-rate the stock if results beat expectations (EPS est. 0.24)."]
["Price action is risk-off today: -5.45% in regular market (and additional weakness pre-market), aligning with broader market weakness (S&P 500 -1.19%).", "Momentum is bearish (MACD negative and widening), increasing the probability support breaks and downside continuation follows.", "Analyst targets are mostly below the current price (limited perceived upside), which can cap dip-buying enthusiasm."]
["Latest quarter: 2025/Q3.", "Revenue: $104.28M, up 25.63% YoY (solid top-line growth).", "Profitability inflection: Net income $3.54M, up 411.13% YoY; EPS $0.09, up 350% YoY.", "Margins improving: Gross margin 45.49, up 8.70% YoY (supports quality of growth)."]
["Recent trend: Mostly Neutral/Market Perform with incremental price target tweaks rather than upgrades.", "2025-11-20 Keefe Bruyette: PT cut to $47 from $50; maintained Market Perform after a weaker-than-expected Q3 (but noted organic revenue outlook intact).", "2025-11-21 UBS: PT raised to $48 from $43; maintained Neutral post-Q3 model update.", "2026-01-02 Keefe Bruyette: PT raised to $52 from $47; maintained Market Perform (sector-wide payment/consumer finance retargeting).", "Wall Street pro view (pros/cons): Pros\u2014acknowledges continued organic revenue outlook and improving fundamentals; Cons\u2014ratings remain non-bullish and targets cluster at/under current price, implying the Street isn\u2019t confident in near-term upside from here."]
